Expert insights. Personalized for you.
The Pharma Data
JULY 31, 2022
When reports showed COVID-19 vaccination rates were lower among racial/ethnic minority groups, most discussions focused on mistrust and misinformation among these populations or their reduced access to health care facilities.
FDA Law Blog
JULY 31, 2022
By Allyson B. Mullen — On July 19, 2022, CDRH announced to users of its Customer Collaborations Portal (CCP) that it is now accepting premarket submissions electronically.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Intouch Solutions
JULY 31, 2022
Authors: Paris Daniell, Jeff Greene, Andrew Grojean, Alex Kareotes, Jeff MacFarland, Nicole Maksimovic, Sarah Morgan, Rachel Stelmach, Carly Stilwell.
Drug Patent Watch
JULY 31, 2022
Annual Drug Patent Expirations for ADDYI Addyi is a drug marketed by Sprout Pharms and is included in one NDA. It is available from one supplier. There are four patents…. The post New patent expiration for Sprout Pharms drug ADDYI appeared first on DrugPatentWatch - Make Better Decisions.
Advertiser: FourKites
Download this a benchmark study from FourKites and The Journal of Commerce exploring how international shippers’ usage of global supply chain visibility technology has evolved since the onset of global disruptions caused by COVID-19.
JAMA Internal Medicine
JULY 31, 2022
This cohort study compares the rate of motor vehicle crashes among patients discharged from the emergency department after first-episode syncope vs conditions other than syncope to determine if more stringent driving restrictions are warranted
Drug Patent Watch
JULY 31, 2022
Annual Drug Patent Expirations for MACRILEN Macrilen is a drug marketed by Novo and is included in one NDA. It is available from two suppliers. There are two patents protecting…. The post New patent expiration for NOVO drug MACRILEN appeared first on DrugPatentWatch - Make Better Decisions.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
|
Drug Patent Watch
JULY 31, 2022
Expiring drug patents are continuously driving innovation, as branded firms seek out new high-margin opportunities. Examining the patent expirations by year can indicate which pharmaceutical companies face the most peril….
JAMA Internal Medicine
JULY 31, 2022
This case report describes a patient in their 70s with a history of paroxysmal atrial fibrillation who presented to the emergency department with complaints of dizziness
Drug Patent Watch
JULY 31, 2022
MACRILEN (macimorelin acetate) Novo Patent: 6,861,409 Expiration: Aug 1, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or…. The post Drug Patent Expirations for the Week of July 31, 2022 appeared first on DrugPatentWatch - Make Better Decisions. Patent Expiration
52 
Let's personalize your content